Naga MounikaDrug Product · Validation · CMC
Menu
Working document

QOS-to-Module-3 Validation Traceability Matrix

A plug-and-play matrix tracing every validation claim in the Quality Overall Summary's 2.3.S.2.5 and 2.3.P.3.5 back to its full support in Module 3, so the summary never asserts more, or less, than the detailed section actually proves, with a filled specimen.

Document typeMatrix
Topic areaRegulatory CMC
LevelAdvanced
UpdatedSeptember 2026
How to use this document

Copy the template below into your quality system. Replace every <<FILL: ...>> placeholder with your company, system, and process specifics, then route it through your own document control, review, and approval. The filled specimen shows one worked example; adapt the numbers and scope to your operation and verify each cited regulation or standard against the current source before you rely on it.

This is a generic, originally worded starting point. It contains no confidential, proprietary, or employer material, it is drafted with AI assistance and reviewed, it is not legal or compliance advice, and adopting it does not by itself create or prove compliance. See the Disclaimer and Terms.

This is a ready-to-use traceability matrix confirming that every claim made in the Quality Overall Summary’s process validation content, 2.3.S.2.5 and 2.3.P.3.5, is fully and accurately supported by Module 3, and that Module 3 contains nothing load-bearing that the QOS silently omits. Run it before a filing goes to final QA and regulatory sign-off. Replace every <<FILL: ...>> placeholder with your own specifics. A filled specimen follows.

Document control header

FieldEntry
Document titleQOS-to-Module-3 Traceability Matrix for <<FILL: product, submission type and number>>
Document number<<FILL>>
Version<<FILL>>
Review date<<FILL>>
Reviewer(s)<<FILL>>

1. Purpose

This matrix maps every validation claim stated in the Quality Overall Summary’s 2.3.S.2.5 and 2.3.P.3.5 to the specific Module 3 content that supports it, so a reviewer moving between the two never finds a QOS statement Module 3 cannot back up, and so nothing genuinely load-bearing in Module 3 is missing from the summary a reviewer reads first.

2. Scope

Applies to <<FILL: submission type, e.g. original BLA, supplement>> for <<FILL: product>>, covering the drug substance and drug product process validation content in both the Quality Overall Summary and Module 3.

3. Method

Read the QOS’s S.2.5 and P.3.5 content sentence by sentence. For each distinct claim, batch count, conclusion, statistical basis, deviation disclosure, or Stage 3 commitment, locate its exact supporting content in Module 3 and record the cross-reference. Then read Module 3’s own S.2.5 and P.3.5 content and confirm every genuinely load-bearing point, anything that would change the conclusion if it were missing, is at least gestured at in the QOS; a QOS that omits a real deviation or a materially qualified conclusion is a disclosure gap, not an acceptable compression.

4. Traceability matrix

#QOS claim (2.3.S.2.5 / 2.3.P.3.5)Module 3 support (3.2.S.2.5 / 3.2.P.3.5 section and location)Fully supported?Notes
1<<FILL: e.g. validation approach and batch count statement>><<FILL>><<FILL: Yes/No>><<FILL>>
2<<FILL: e.g. PPQ conclusion sentence>><<FILL>><<FILL>><<FILL>>
3<<FILL: e.g. reference to Stage 3 CPV commitment>><<FILL>><<FILL>><<FILL>>
4<<FILL: e.g. reference to a comparability or flexibility-guidance basis>><<FILL>><<FILL>><<FILL>>

Add one row per distinct claim; a QOS paragraph of two or three sentences typically yields three to five rows.

5. Reverse check: Module 3 content not reflected in the QOS

#Module 3 contentIs it load-bearing for the conclusion?Reflected in QOS?Action
<<FILL>><<FILL: e.g. a disclosed PPQ deviation and its resolution>><<FILL: Yes/No>><<FILL: Yes/No>><<FILL: add a QOS sentence / no action, non-load-bearing detail appropriately left to Module 3>>

A “No” in the load-bearing column with a “No” in the reflected column is the expected, correct state; a “Yes” and “No” pairing on the same row is the finding this section exists to catch.

6. Disposition

FieldEntry
Total QOS claims checked<<FILL>>
Claims not fully supported by Module 3 (blocks sign-off until resolved)<<FILL>>
Load-bearing Module 3 content missing from the QOS (blocks sign-off until resolved)<<FILL>>
RecommendationApprove QOS and Module 3 content as consistent / Hold pending resolution of item(s) <<FILL>>

7. References

See the paired article, writing CMC validation summaries for regulatory filings, for the reasoning behind the QOS-versus-Module-3 discipline this matrix checks. ICH M4Q, Common Technical Document, Quality (informal Quality Overall Summary length guidance: roughly 40 pages of text excluding tables and figures, extending to roughly 80 pages for biotech products or products made by more complex processes).

8. Revision history

VersionDateAuthorSummary of change
<<FILL: 1.0>><<FILL>><<FILL>>Initial issue.

9. Approvals

RoleNameSignatureDate
Reviewer (Regulatory writer)<<FILL>>
Approver (Regulatory Affairs Lead)<<FILL>>

Filled specimen

Extract for an example cell therapy BLA’s S.2.5 content. Company and product are illustrative.

#QOS claimModule 3 supportFully supported?Notes
1”Process validation followed traditional process validation across two commercial-scale batches, reflecting the total batches manufactured at commercial scale to date.”3.2.S.2.5, paragraph 1, states the same approach and batch count; batch matrix table in 3.2.S.2.5 lists both batches by IDYesWording matches; no independent claim introduced
2”See 3.2.S.2.5 for the batch-count rationale and PPQ results.”3.2.S.2.5, paragraphs 2 through 4, and the master PPQ summary tableYesPointer is accurate and specific enough for a reviewer to navigate directly

Reverse check finding: Module 3’s 3.2.S.2.5 discloses a minor in-PPQ deviation (a processing hold-time excursion, resolved with no CQA impact) in its narrative. The QOS made no mention of it at all, not even a general statement that a deviation occurred and was resolved. Determination: this deviation is load-bearing enough to warrant at least a one-clause acknowledgment at the QOS level, since a QOS that reads as a flawless two-batch campaign when Module 3 discloses a real deviation creates exactly the inconsistency this matrix exists to catch. Action: added the clause “one minor processing deviation occurred and was resolved with no impact on product quality; see 3.2.S.2.5” to the QOS paragraph.

Common findings this matrix prevents

  • A QOS conclusion stated more strongly, or with fewer caveats, than the Module 3 data it summarizes actually supports.
  • A real deviation or qualification disclosed honestly in Module 3 but invisible in the QOS, so a reviewer who reads the QOS alone forms a more favorable impression than the full record supports.
  • A QOS cross-reference that points to the wrong Module 3 section or an outdated version, discovered only when a reviewer tries to follow it.
  • A QOS drafted before a late Module 3 revision, never reconciled back to the final text.

How to adapt this matrix

  1. Run this matrix after Module 3’s validation content is finalized, not before, since reconciling the QOS against a still-changing Module 3 wastes the exercise.
  2. Populate section 4 by reading the QOS literally sentence by sentence; do not summarize the QOS from memory of what it is supposed to say.
  3. Take the reverse check in section 5 seriously; the more common failure is an omission from the QOS, not an overstatement in it.
  4. Re-run this matrix if either the QOS or Module 3 content changes after this review, even a small wording change, since a cross-reference or claim can silently break.
Add this site to your home screen Full screen, works offline, one tap from your home screen.